The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up

Clinical Practice ◽

Bowel Disease ◽

Safety Profile ◽

Tumour Necrosis ◽

Practice Analysis ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2009.04112.x ◽

2010 ◽

Vol 31 (1) ◽

pp. 20-34 ◽

Cited By ~ 75

Author(s):

M. J. SHALE ◽

C. H. SEOW ◽

C. S. COFFIN ◽

G. G. KAPLAN ◽

R. PANACCIONE ◽

...

Keyword(s):

Viral Infection ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Review Article ◽

Chronic Viral Infection ◽

Factor Therapy ◽

Inflammatory Bowel ◽

DOP009 Comparative safety profile of vedolizumab and tumour necrosis factor–antagonist therapy for inflammatory bowel disease: a multicentre consortium propensity score-matched analysis

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjx180.046 ◽

2018 ◽

Vol 12 (supplement_1) ◽

pp. S036-S036 ◽

Cited By ~ 5

Author(s):

D Lukin ◽

A Weiss ◽

S Aniwan ◽

S Kadire ◽

G Tran ◽

...

Keyword(s):

Propensity Score ◽

Bowel Disease ◽

Safety Profile ◽

Tumour Necrosis ◽

Antagonist Therapy ◽

Inflammatory Bowel ◽

Comparative Safety ◽

Factor Antagonist ◽

Systematic review and meta-analysis of dermatological reactions in patients with inflammatory bowel disease treated with anti-tumour necrosis factor therapy

European Journal of Gastroenterology & Hepatology ◽

10.1097/meg.0000000000001917 ◽

2020 ◽

Vol Publish Ahead of Print ◽

Author(s):

Gaurav B. Nigam ◽

Anirudh P. Bhandare ◽

George A. Antoniou ◽

Jimmy K. Limdi

Keyword(s):

Systematic Review ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Meta Analysis ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Methotrexate for psoriasiform lesions associated with anti-tumour necrosis factor therapy in inflammatory bowel disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2012.05082.x ◽

2012 ◽

Vol 35 (10) ◽

pp. 1175-1180 ◽

Cited By ~ 15

Author(s):

A. Buisson ◽

J.-F. Cuny ◽

A. Barbaud ◽

J.-L. Schmutz ◽

M.-A. Bigard ◽

...

Keyword(s):

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Factor Therapy ◽

Inflammatory Bowel ◽

NICE guidance for anti-tumour necrosis factor therapy in Crohn's disease: what does it mean for the inflammatory bowel disease community?

Frontline Gastroenterology ◽

10.1136/fg.2010.001545 ◽

2010 ◽

Vol 1 (3) ◽

pp. 144-146 ◽

Cited By ~ 3

Author(s):

T. Orchard

Keyword(s):

Crohn’S Disease ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Nice Guidance ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Necrosis Factor ◽

Disease Community

Extra-pulmonary Reactivation of Latent Tuberculosis After Initiation of Anti-tumour Necrosis Factor Therapy for Inflammatory Bowel Disease—Are Current Screening Strategies Adequate?

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjw204 ◽

2016 ◽

pp. jjw204 ◽

Cited By ~ 1

Author(s):

Thomas H. Tranah ◽

Shin Y. Luk ◽

Markus Gess

Keyword(s):

Bowel Disease ◽

Tumour Necrosis ◽

Latent Tuberculosis ◽

Screening Strategies ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Extra Pulmonary ◽

Current Screening ◽

Paradoxical psoriasiform reactions of anti-tumour necrosis factor therapy in inflammatory bowel disease patients

Internal Medicine Journal ◽

10.1111/imj.13637 ◽

2017 ◽

Vol 47 (12) ◽

pp. 1445-1448 ◽

Cited By ~ 4

Author(s):

Faseeha C. Peer ◽

Andrew Miller ◽

Paul Pavli ◽

Kavitha Subramaniam

Keyword(s):

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Factor Therapy ◽

Inflammatory Bowel ◽

The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease

British Medical Bulletin ◽

10.1093/bmb/ldp036 ◽

2009 ◽

Vol 92 (1) ◽

pp. 61-77 ◽

Cited By ~ 21

Author(s):

M. J. Shale

Keyword(s):

Viral Infection ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Frequent Conversion of Tuberculosis Screening Test During Anti-Tumour Necrosis Factor Therapy in Chinese Patients with Inflammatory Bowel Disease: A Prospective Study with 3 Years Follow-Up

Gastroenterology ◽

10.1016/s0016-5085(17)31534-2 ◽

2017 ◽

Vol 152 (5) ◽

pp. S387

Author(s):

Siew C. Ng ◽

Margaret Ip ◽

L.S. Tam ◽

Esther H. Hung ◽

Whitney Tang ◽

...

Keyword(s):

Prospective Study ◽

Tumour Necrosis ◽

Chinese Patients ◽

Tuberculosis Screening ◽

Factor Therapy ◽

Inflammatory Bowel ◽

A Prospective Study ◽

P584. Relapse risk and predictors for relapse in a real-life cohort of inflammatory bowel disease patients after discontinuation of anti-tumour necrosis factor therapy

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjw019.703 ◽

2016 ◽

Vol 10 (suppl 1) ◽

pp. S397.1-S397

Keyword(s):

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Real Life ◽

Relapse Risk ◽

Factor Therapy ◽

Inflammatory Bowel ◽